ClinicalTrials.Veeva

Menu

The Role of Bifidobacterium Intervention in Food Allergic Infants

Shanghai Jiao Tong University logo

Shanghai Jiao Tong University

Status

Completed

Conditions

Food Allergy in Infants

Treatments

Dietary Supplement: Bifidobacterium M-16V
Other: allergy food avoidance

Study type

Interventional

Funder types

Other

Identifiers

NCT05965063
BifidobacteriumRJH

Details and patient eligibility

About

Infant food protein allergy is the most common allergic disease in children, which can lead to infantile-specific dermatitis, intestinal inflammation, and so on. Dietary avoidance is a common strategy for food protein allergy in infants and young children. However, the hidden etiology of food protein allergy or multiple food allergies often leads to poor efficacy. The aim of this study is to observe the clinical effectiveness of Bifidobacterium intervention on food allergy.

Enrollment

180 patients

Sex

All

Ages

Under 12 months old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 0 -12 months infant
  • Infants that are allergic (confirmed by an allergist) to at least one of the main food allergens (cow's milk, egg, soy or wheat) and is following an elimination diet to at least one of these allergens.

Exclusion criteria

  • Patients had used probiotics within 1 month prior to the study
  • Allergy or intolerance to probiotics or their excipient
  • Serious primary diseases of the cardiovascular, nervous, respiratory,hepatobiliary immunology,and endocrine systems;

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

180 participants in 3 patient groups

Dietary avoidance for allergy food
Other group
Description:
strict avoidance of the specific allergenic food
Treatment:
Other: allergy food avoidance
bifidobacterium intervention
Experimental group
Description:
Bifidobacterium M-16V for 12 weeks while strictly avoidance of the specific allergenic food
Treatment:
Dietary Supplement: Bifidobacterium M-16V
Healthy control
No Intervention group
Description:
without intervention

Trial contacts and locations

1

Loading...

Central trial contact

XINQIONG WANG; Yi Yu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems